These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 33358969)
1. Technological innovation of Continuous Glucose Monitoring (CGM) as a tool for commercial aviation pilots with insulin-treated diabetes and stakeholders/regulators: A new chance to improve the directives? Strollo F; Furia A; Verde P; Bellia A; Grussu M; Mambro A; Petrelli MD; Gentile S Diabetes Res Clin Pract; 2021 Feb; 172():108638. PubMed ID: 33358969 [TBL] [Abstract][Full Text] [Related]
2. A UK Civil Aviation Authority protocol to allow pilots with insulin-treated diabetes to fly commercial aircraft. Mitchell SJ; Hine J; Vening J; Montague J; Evans S; Shaw KM; Frier BM; Heller SR; Russell-Jones DL Lancet Diabetes Endocrinol; 2017 Sep; 5(9):677-679. PubMed ID: 28842157 [No Abstract] [Full Text] [Related]
3. Medical Certification of Pilots Through the Insulin-Treated Diabetes Mellitus Protocol at the FAA. Stanwyck LK; DeVoll JR; Pastore J; Gamble Z; Poe A; Gui GV Aerosp Med Hum Perform; 2022 Aug; 93(8):627-632. PubMed ID: 36050848 [No Abstract] [Full Text] [Related]
4. Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol: A Preliminary Feasibility Study. Garden GL; Shojaee-Moradie F; Hutchison EJ; Frier BM; Shaw KM; Heller SR; Koehler G; Mader JK; Maher D; Roberts GA; Russell-Jones DL Diabetes Technol Ther; 2023 Aug; 25(8):543-548. PubMed ID: 37384853 [No Abstract] [Full Text] [Related]
5. Continuous Glucose Monitoring for In-Flight Measurement of Glucose Levels of Insulin-Treated Pilots. Strollo F; Simons R; Mambro A; Strollo G; Gentile S Aerosp Med Hum Perform; 2019 Aug; 90(8):735-737. PubMed ID: 31331425 [No Abstract] [Full Text] [Related]
6. Pilots flying with insulin-treated diabetes. Russell-Jones DL; Hutchison EJ; Roberts GA Diabetes Obes Metab; 2021 Jul; 23(7):1439-1444. PubMed ID: 33710744 [TBL] [Abstract][Full Text] [Related]
7. The U.S. Experience with Waivers for Insulin-Treated Pilots. Mills WD; DeJohn CA; Alaziz M Aerosp Med Hum Perform; 2017 Jan; 88(1):34-41. PubMed ID: 28061920 [TBL] [Abstract][Full Text] [Related]
8. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Cappon G; Vettoretti M; Sparacino G; Facchinetti A Diabetes Metab J; 2019 Aug; 43(4):383-397. PubMed ID: 31441246 [TBL] [Abstract][Full Text] [Related]
9. The U.S. Experience with Special Issuance Waivers. Mills WD; Davis JT Aerosp Med Hum Perform; 2018 Oct; 89(10):905-911. PubMed ID: 30219118 [TBL] [Abstract][Full Text] [Related]
10. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Rodbard D Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879 [TBL] [Abstract][Full Text] [Related]
12. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study. Pazos-Couselo M; García-López JM; González-Rodríguez M; Gude F; Mayán-Santos JM; Rodríguez-Segade S; Rodríguez-García J; Casanueva F Can J Diabetes; 2015 Oct; 39(5):428-33. PubMed ID: 26254702 [TBL] [Abstract][Full Text] [Related]
13. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study. Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746 [TBL] [Abstract][Full Text] [Related]
14. An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects. Facchinetti A; Del Favero S; Sparacino G; Cobelli C IEEE Trans Biomed Eng; 2013 Feb; 60(2):406-16. PubMed ID: 23193300 [TBL] [Abstract][Full Text] [Related]
15. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections. Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183 [TBL] [Abstract][Full Text] [Related]
16. How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring? Ajjan RA Diabetes Technol Ther; 2017 May; 19(S2):S27-S36. PubMed ID: 28541132 [TBL] [Abstract][Full Text] [Related]
17. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Pickup JC; Ford Holloway M; Samsi K Diabetes Care; 2015 Apr; 38(4):544-50. PubMed ID: 25552422 [TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials. Szypowska A; Ramotowska A; Dzygalo K; Golicki D Eur J Endocrinol; 2012 Apr; 166(4):567-74. PubMed ID: 22096111 [TBL] [Abstract][Full Text] [Related]
20. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial. Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]